Skip to main content
PMC home page
Proceedings of the Royal Society of Medicine logoLink to Proceedings of the Royal Society of Medicine
. 1967 Feb;60(2):130–133.

Immunosuppressive drugs in the management of malignant and severe rheumatoid arthritis.

M F Kahn, M Bedoiseau, S de Sèze
PMCID: PMC1901593  PMID: 4163645

Full text

PDF
130

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Brocteur J., Moens C. Treatment of rheumatoid arthritis with immunosuppressive drugs. II. Immunological study. Acta Rheumatol Scand. 1965;11(3):221–230. doi: 10.3109/rhe1.1965.11.issue-1-4.26. [DOI] [PubMed] [Google Scholar]
  2. DAMESHEK W., SCHWARTZ R. Treatment of certain "autoimmune" diseases with antimetabolites; a preliminary report. Trans Assoc Am Physicians. 1960;73:113–127. [PubMed] [Google Scholar]
  3. DEMIS D. J., BROWN C. S., CROSBY W. H. THIOGUANINE IN THE TREATMENT OF CERTAIN AUTOIMMUNE, IMMUNOLOGIC AND RELATED DISEASES. Am J Med. 1964 Aug;37:195–205. doi: 10.1016/0002-9343(64)90005-1. [DOI] [PubMed] [Google Scholar]
  4. EISEN B., DEMIS D. J., CROSBY W. H. Thioguanine therapy. Systemic lupus erythematosus, atopic dermatitis, and other nonmalignant diseases. JAMA. 1962 Mar 10;179:789–791. [PubMed] [Google Scholar]
  5. FLATT A. E. Intraarticular Thio-tepa in rheumatoid disease of the hands. Rheumatism. 1962 Oct;18:70–73. [PubMed] [Google Scholar]
  6. HITCHINGS G. H., ELION G. B. Chemical suppression of the immune response. Pharmacol Rev. 1963 Jun;15:365–405. [PubMed] [Google Scholar]
  7. JIMENEZ DIAZ C., LOPEZ GARCIA E., MERCHANTE A., PERIANES J. Treatment of rheumatoid arthritis with nitrogen mustard; preliminary report. J Am Med Assoc. 1951 Dec 8;147(15):1418–1419. [PubMed] [Google Scholar]
  8. KALLIOMAEKI J. L., SAARIMAA H. A., TOIVANEN P. INHIBITION BY 6-MERCAPTOPURINE OF POLYARTHRITIS INDUCED BY FREUND'S ADJUVANT. Ann Rheum Dis. 1964 Jan;23:78–80. doi: 10.1136/ard.23.1.78. [DOI] [PMC free article] [PubMed] [Google Scholar]
  9. LANGE K., ORES R., STRAUSS W., WACHSTEIN M. STEROID THERAPY OF SYSTEMIC LUPUS ERYTHEMATOSUS BASED ON IMMUNOLOGIC CONSIDERATIONS. Arthritis Rheum. 1965 Apr;8:244–259. doi: 10.1002/art.1780080208. [DOI] [PubMed] [Google Scholar]
  10. Lorenzen I., Videbaek A. Treatment of collagen diseases with cytostatics. Lancet. 1965 Sep 18;2(7412):558–561. doi: 10.1016/s0140-6736(65)90866-4. [DOI] [PubMed] [Google Scholar]
  11. Moens C., Brocteur J. Treatment of rheumatoid arthritis with immunosuppressive drugs. I. Clinical study. Acta Rheumatol Scand. 1965;11(3):212–220. doi: 10.3109/rhe1.1965.11.issue-1-4.25. [DOI] [PubMed] [Google Scholar]
  12. ROBECCHI A., CARTESEGNA F., DANEO V. Quelques considérations sur 69 cas de polyarthrite chronique evolutive traités par le chlorhydrate de méthyl-bis-beta-chloro-éthyl-amine. Rev Rhum Mal Osteoartic. 1954 Dec;21(12):823–828. [PubMed] [Google Scholar]
  13. Santos G. W., Owens A. H. Production of graft-versus-host disease in the rat and its treatment with cytotoxic agents. Nature. 1966 Apr 9;210(5032):139–140. doi: 10.1038/210139a0. [DOI] [PubMed] [Google Scholar]
  14. WARD J. R., CLOUD R. S., KRAWITT E. L., JONES R. S. STUDIES ON ADJUVANT-INDUCED POLYARTHRITIS IN RATS. 3. THE EFFECT OF "IMMUNOSUPPRESSIVE AGENTS" ON ARTHRITIS AND TUBERCULIN HYPERSENSITIVITY. Arthritis Rheum. 1964 Dec;7:654–661. doi: 10.1002/art.1780070605. [DOI] [PubMed] [Google Scholar]
  15. de Sèze S., Kahn M. F., Debeyre N., Cayla G., Lisfranc S. Evolution favorable d'un cas d'angéite nécrosante survenu au cours d'une polyarthrite rhumatoïde et traité par pénicillamine et chlorambucil. Présentation de malade. Rev Rhum Mal Osteoartic. 1965 May;32(5):259–262. [PubMed] [Google Scholar]

Articles from Proceedings of the Royal Society of Medicine are provided here courtesy of Royal Society of Medicine Press

RESOURCES